SCOTTSDALE, ARIZONA -- (MARKET WIRE) -- December 13, 2006 -- Holmes Biopharma, Inc. (PINK SHEETS: HLMB) announced that the Company has entered into a letter of intent to purchase an existing, profitable pharmaceutical development, clinical manufacture, biotechnology, and analytical laboratory business located in the eastern United States. The name and terms of the acquisition will be disclosed after a formal purchase agreement is completed in the coming weeks.
